Home › Idiopathic Pulmonary Fibrosis › North Carolina › Durham
Idiopathic Pulmonary Fibrosis clinical trials in Durham, NC
6 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 2
- UNC Chapel Hill, Chapel Hill · 10 mi away
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- Duke University, Durham
- UNC Chapel Hill, Chapel Hill · 10 mi away
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 2
- WISPer Site in Durham, NC, Durham
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
RecruitingPhase 2
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi away
Idiopathic Pulmonary Fibrosis trials in other cities
- Birmingham, AL9 studies
- New York City, NY8 studies
- Kansas City, KS7 studies
- Los Angeles, CA7 studies
- Philadelphia, PA7 studies
- Chicago, IL6 studies
- Aurora, CO6 studies
- Nashville, TN5 studies
- Dallas, TX5 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
- Charleston, SC5 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.